Investors
Key press releases
Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on the Euronext Growth Paris (ticker: ALCLS).
Cellectis ADS (Nasdaq)
Ticker: CLLS
$3.4100
+0.0300 (0.8876%)
- Prev. close
- 3.3800
- Volume
- 28,662
- High
- 3.5000
- Capitalization
- 245.839M
Cellectis (Euronext Growth Paris)
Ticker: ALCLS
€3.1050
+0.0950 (3.1561%)
- Prev. close
- 3.0100
- Volume
- 249,903
- High
- 3.1200
- Capitalization
- 223.851M
Covering research analysts
Barclays - Etzer Darout
Bryan Garnier - Oscar Haffen-Lamm
Citizens Bank - Silvan Tuerkcan
Clear Street - Bill Maughan
Goldman Sachs - Salveen Richter
Jefferies - Amin Makarem
Kempen - Sebastiaan van der Schoot
Oddo BHF - Martial Descoutures
RW Baird - Jack Allen
Wells Fargo – Yanan Zhu
Cellectis contact information
Arthur Stril, Chief Financial Officer & Chief Business Officer
Citibank ADR contact information
Intermediaries & Investors
US: +1 212 723 5435
UK: +44 207 500 2030
Société Générale Securities Services - Ordinary Shares contact information
Call center in English and French
Monday to Friday from 8:30am to 6pm CEST
+33 (0)2 51 85 67 89